Knowles reported Q2 2024 financial results with revenues of $204.7 million, an 18% increase year-over-year, and net cash from operating activities of $24.9 million. Non-GAAP diluted earnings per share were $0.24, in line with expectations. The company expects revenue growth in Medtech and Specialty Audio and Precision Devices segments in Q3 2024.
Revenues increased 18% year-over-year to $204.7 million.
Non-GAAP diluted earnings per share were $0.24.
Net cash from operating activities was $24.9 million.
Company expects sequential and year-over-year revenue growth in Medtech and Specialty Audio and Precision Devices segments in Q3 2024.
The forward looking guidance for the quarter ending September 30, 2024 is as follows: Revenues $210 to $220 million, Diluted earnings per share $0.20 to $0.24, Net cash provided by operating activities $35 to $45 million.